Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) PT at $166.90
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has issued a strong buy recommendation on […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has issued a strong buy recommendation on […]
